Non-Hodgkin Lymphoma

Showing NaN - NaN of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

Recruiting
  • Non-Hodgkin Lymphoma
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • NKTR-255 at 1.5 µg/kg
  • +3 more
  • La Jolla, California
  • +26 more
Jan 10, 2023

Non-Hodgkin Lymphoma Trial in Worldwide (Tisagenlecleucel after optional bridging and lymphodepleting chemo, Platinum-based

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy
  • Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and autologous hematopoietic stem cell transplant (HSCT)
  • La Jolla, California
  • +66 more
Jan 6, 2023

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in United States (JCAR017 (lisocabtagene

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • JCAR017 (lisocabtagene maraleucel) single-dose schedule
  • JCAR017 (lisocabtagene maraleucel) 2-dose schedule
  • Birmingham, Alabama
  • +24 more
Nov 21, 2022

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Chicago, Illinois
  • +2 more
Aug 19, 2022

Non-hodgkin Lymphoma Trial in United States (MT-3724)

Terminated
  • Non-hodgkin Lymphoma
  • Whittier, California
  • +4 more
Jul 18, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)

Recruiting
  • B-cell Malignancy
  • +3 more
  • CTX110
  • Los Angeles, California
  • +27 more
May 6, 2022

Collecting and Storing Tissue Samples From Rare or Cutaneous

Active, not recruiting
  • Adult Immunoblastic Lymphoma
  • +12 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +129 more
Mar 23, 2022

Non-hodgkin Lymphoma, Hodgkin Lymphoma, Lymphoma Trial in Chicago (Radiation - Dose Level 0, Radiation - Dose Level 1, Radiation

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • Radiation - Dose Level 0
  • +4 more
  • Chicago, Illinois
    University of Chicago
Dec 3, 2021

Anaplastic Large-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin,

Completed
  • Anaplastic Large-Cell Lymphoma
  • +2 more
  • brentuximab vedotin
  • +4 more
  • Gilbert, Arizona
  • +143 more
Nov 1, 2021

The Second Multicenter Hemophilia Cohort Study

Completed
  • Liver Decompensation
  • +2 more
    • Tucson, Arizona
    • +47 more
    Dec 14, 2019

    Non-Hodgkin Lymphoma, Hodgkin Disease, Thrombocytopenia Trial in Worldwide ((PN-152,243)/ PN-196,444)

    Completed
    • Non-Hodgkin Lymphoma
    • +2 more
    • (PN-152,243)/ PN-196,444
    • Phoenix, Arizona
    • +37 more
    May 3, 2007